| Intervention Drugs |
Condition |
Sponsor |
Patients enrolled |
Phase |
Period |
Clinical trial number |
| Vorinostat (SAHA), Cisplatin, Radiation |
Stage III or IV of SCC of the oropharynx |
Ohio University Comprehensive Cancer Center |
38 |
I |
2010
2013 |
NCT01064921 |
| Capecitabine (Xeloda), Vorinostat (SAHA) |
Recurrent and/or metastatic head and neck cancer,
Nasopharyngeal carcinoma, stage III and IV HNSSC and verrucous carcinoma |
National (NCI) Cancer Institute |
1445 |
II |
2010
2013 |
NCT01267240 |
| CUDC-101
Cisplatin, Radiation |
Head and neck cancer |
Curis, Inc. |
22 |
I |
2011
2013 |
NCT01384799 |
| Valproic acid, Patinum and Radiation |
Locally advanced head and neck SCC (oral cavity and oropharynx) |
Intituto do Cancer do Estado de São Paulo |
40 |
II |
2012
2014 |
NCT01695122 |
SCC: Squamous Cell Carcinoma; HNSCC: Head and Neck Squamous Cell Carcinoma
